Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 3 of 4 for:    Liberty 1

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) (LIBERTY2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02736149
Recruitment Status : Terminated (Following the failure to demonstrate efficacy in EIG-UBX-001, the sponsor decided to terminate Study EIG-UBX-002.)
First Posted : April 13, 2016
Last Update Posted : July 18, 2019
Information provided by (Responsible Party):
Eiger BioPharmaceuticals